These metabolites interact with L-cells in your intestinal lining, which are the cells responsible for producing GLP-1
Umigai N, Takeda R, Mori A
Much of the discussion about GLP-1 agonists has focused on weight loss and diabetes
Finally, the market is characterized by attractive drivers, prospects, and trends
Although not approved specifically for PCOS, GLP-1 RA use in women with PCOS has been associated with improved blood glucose control and weight loss, as well as improvements in menstrual regularity and a decrease in ovarian cysts ( 4 , 6 8 )
Dosing NAC at 6001200mg daily increases hepatic glutathione production by supplying cysteine without the bioavailability constraints of intact glutathione